Fibrinogen and fibrin based micro and nano scaffolds incorporated with drugs, proteins, cells and genes for therapeutic biomedical applications
暂无分享,去创建一个
[1] D. Steed,et al. Reversal of impaired wound repair in iNOS-deficient mice by topical adenoviral-mediated iNOS gene transfer. , 1998, The Journal of clinical investigation.
[2] G. Wnek,et al. Mechanical properties of electrospun fibrinogen structures. , 2006, Acta biomaterialia.
[3] A. G. Ding,et al. Rescue of SCID murine ischemic hindlimbs with pH-modified rhbFGF/poly(DL-lactic-co-glycolic acid) implants. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[4] B. Blombäck,et al. A two-step fibrinogen–fibrin transition in blood coagulation , 1978, Nature.
[5] Yoshihiro Ito,et al. A chimeric epidermal growth factor with fibrin affinity promotes repair of injured keratinocyte sheets. , 2009, Acta biomaterialia.
[6] M. Gyöngyösi,et al. Role of adult bone marrow stem cells in the repair of ischemic myocardium: current state of the art. , 2008, Experimental hematology.
[7] S. Andreadis,et al. Engineering of fibrin-based functional and implantable small-diameter blood vessels. , 2005, American journal of physiology. Heart and circulatory physiology.
[8] P. Simpson‐Haidaris,et al. Matrix-fibrinogen enhances wound closure by increasing both cell proliferation and migration. , 2003, Blood.
[9] R. Hynes,et al. Effects of LETS glycoprotein on cell motility , 1978, Cell.
[10] M. Fussenegger,et al. Stabilization of fibrin-chondrocyte constructs for cartilage reconstruction. , 1999, Annals of plastic surgery.
[11] D. Seliktar,et al. The biocompatibility of PluronicF127 fibrinogen-based hydrogels. , 2010, Biomaterials.
[12] C Perka,et al. Joint cartilage repair with transplantation of embryonic chondrocytes embedded in collagen-fibrin matrices. , 2000, Clinical and experimental rheumatology.
[13] W. Anderson,et al. Site-directed neovessel formation in vivo. , 1988, Science.
[14] T. Nakamura,et al. Acceleration of wound healing in diabetic mice by basic fibroblast growth factor. , 1996, Biological & pharmaceutical bulletin.
[15] W. Saltzman,et al. Controlled delivery of VEGF via modulation of alginate microparticle ionic crosslinking. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[16] P. Janmey,et al. Fibrin gels and their clinical and bioengineering applications , 2009, Journal of The Royal Society Interface.
[17] D. Carroll,et al. The mechanical properties of individual, electrospun fibrinogen fibers. , 2009, Biomaterials.
[18] G. Siegel,et al. Neurotrophic factors in Alzheimer’s and Parkinson’s disease brain , 2000, Brain Research Reviews.
[19] A. Davies. The role of neurotrophins in the developing nervous system. , 1994, Journal of neurobiology.
[20] M. Wiberg,et al. Phenotypic and functional characteristics of mesenchymal stem cells differentiated along a Schwann cell lineage , 2006, Glia.
[21] Hinrich Wiese,et al. Long-term stable fibrin gels for cartilage engineering. , 2007, Biomaterials.
[22] Mauro Alini,et al. Fibrin-polyurethane composites for articular cartilage tissue engineering: a preliminary analysis. , 2005, Tissue engineering.
[23] Jan P Stegemann,et al. Influence of thrombin concentration on the mechanical and morphological properties of cell-seeded fibrin hydrogels. , 2007, Acta biomaterialia.
[24] Young Ha Kim,et al. Efficient revascularization by VEGF administration via heparin-functionalized nanoparticle-fibrin complex. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[25] Hsing-Wen Sung,et al. Crosslinking of biological tissues using genipin and/or carbodiimide. , 2003, Journal of biomedical materials research. Part A.
[26] L Sedel,et al. A biodegradable fibrin scaffold for mesenchymal stem cell transplantation. , 2003, Biomaterials.
[27] J. Davidson,et al. Wound-healing defects in mice lacking fibrinogen. , 2001, Blood.
[28] L. Shea,et al. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. , 2008, Biomaterials.
[29] Yan Jin,et al. Reconstruction of a tissue‐engineered skin containing melanocytes , 2007, Cell biology international.
[30] G. Pierer,et al. Fibrin matrix for suspension of regenerative cells in an artificial nerve conduit. , 2008, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.
[31] S. Vukicevic,et al. Regeneration of the skeleton by recombinant human bone morphogenetic proteins. , 2007, Collegium antropologicum.
[32] L. Zacharski,et al. The role of fibrin in tumor metastasis , 1992, Cancer and Metastasis Reviews.
[33] S. Cadrin,et al. A Preliminary Analysis , 2005 .
[34] A. Vexler,et al. Fibrin microbeads (FMB) as biodegradable carriers for culturing cells and for accelerating wound healing. , 2004, Methods in molecular biology.
[35] K. Chennazhi,et al. Curcumin loaded fibrinogen nanoparticles for cancer drug delivery. , 2011, Journal of biomedical nanotechnology.
[36] A. Jayakrishnan,et al. Glutaraldehyde as a fixative in bioprostheses and drug delivery matrices. , 1996, Biomaterials.
[37] M. Handl,et al. Novel composite hyaluronan/type I collagen/fibrin scaffold enhances repair of osteochondral defect in rabbit knee. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[38] D. Poppas,et al. Transforming growth factor‐β2 (TGF‐β2) reverses the inhibitory effects of fibrin sealant on cutaneous wound repair in the pig , 2002, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[39] B. Kundu,et al. Role of polypeptides in the treatment and diagnosis of osteoporosis 1 CDRI communication No. 5879. 1 , 1999, Peptides.
[40] K. Kataoka,et al. Polymeric micelles from poly(ethylene glycol)–poly(amino acid) block copolymer for drug and gene delivery , 2009, Journal of The Royal Society Interface.
[41] E. Rodriguez-Merchan,et al. The use of fibrin glue in surgery of the knee. , 2010, The Journal of bone and joint surgery. British volume.
[42] J. Hubbell,et al. Development of fibrin derivatives for controlled release of heparin-binding growth factors. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[43] R. Bucala,et al. Circulating Fibrocytes Define a New Leukocyte Subpopulation That Mediates Tissue Repair , 1994, Molecular medicine.
[44] M. Furlan,et al. Cross-linking of human fibrinogen with glutaraldehyde and tetranitromethane. , 1975, Thrombosis research.
[45] Matthias P Lutolf,et al. Biopolymeric delivery matrices for angiogenic growth factors. , 2003, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.
[46] N. Bark,et al. Fibrinopeptides and fibrin gel structure. , 2004, Biophysical chemistry.
[47] Yves-Alain Barde,et al. Neurotrophin-3 enhances sprouting of corticospinal tract during development and after adult spinal cord lesion , 1994, Nature.
[48] J. David,et al. A macrophage surface component related to fibronectin is involved in the response to migration inhibitory factor. , 1981, Cellular immunology.
[49] H. Greisler,et al. Mitogenicity and release of vascular endothelial growth factor with and without heparin from fibrin glue. , 2000, Journal of vascular surgery.
[50] Gary E. Wnek,et al. Electrospinning of Nanofiber Fibrinogen Structures , 2003 .
[51] G. Bowlin,et al. Electrospun nanofibre fibrinogen for urinary tract tissue reconstruction , 2007, Biomedical materials.
[52] G. Daculsi,et al. Osteogenic properties of calcium phosphate ceramics and fibrin glue based composites , 2007, Journal of materials science. Materials in medicine.
[53] Freddy Yin Chiang Boey,et al. Implanted cardiovascular polymers: Natural, synthetic and bio-inspired , 2008 .
[54] H. Paik,et al. Development of fibrinogen microspheres as a biodegradable carrier for tissue engineering , 2011 .
[55] H. Bianco-Peled,et al. Nanostructuring of PEG-fibrinogen polymeric scaffolds. , 2010, Acta biomaterialia.
[56] P. Dimuzio,et al. Tissue engineering applications to vascular bypass graft development: the use of adipose-derived stem cells. , 2007, Journal of vascular surgery.
[57] Martin Ehrbar,et al. Endothelial cell proliferation and progenitor maturation by fibrin-bound VEGF variants with differential susceptibilities to local cellular activity. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[58] Masataka Deie,et al. Meniscal repair using bone marrow-derived mesenchymal stem cells: experimental study using green fluorescent protein transgenic rats. , 2005, The Knee.
[59] 石村 雅男. Arthroscopic Meniscal Repair Using Fibrin Glue , 1998 .
[60] Jia-cong Shen,et al. A polylactide/fibrin gel composite scaffold for cartilage tissue engineering: fabrication and an in vitro evaluation , 2009, Journal of materials science. Materials in medicine.
[61] J. Hubbell,et al. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. , 2000, Journal of controlled release : official journal of the Controlled Release Society.
[62] M. Raida,et al. In vivo degradation of human fibrinogen A alpha: detection of cleavage sites and release of antithrombotic peptides. , 1995, Biochemical and biophysical research communications.
[63] Enrica Briganti,et al. A composite fibrin-based scaffold for controlled delivery of bioactive pro-angiogenetic growth factors. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[64] J. Isner,et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimal hyperplasia in balloon-injured rat carotid artery. , 1995, Circulation.
[65] M. Ueda,et al. Bone regeneration following injection of mesenchymal stem cells and fibrin glue with a biodegradable scaffold. , 2003, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[66] Catalina Wong,et al. Fibrin-based biomaterials to deliver human growth factors , 2003, Thrombosis and Haemostasis.
[67] J. Rubin,et al. Keratinocyte Growth Factor: A Fibroblast Growth Factor Family Member with Unusual Target Cell Specificity , 1991, Annals of the New York Academy of Sciences.
[68] N. Vrana,et al. Characterization of Poly(vinyl alcohol)/Chitosan Hydrogels as Vascular Tissue Engineering Scaffolds , 2008 .
[69] J. Hubbell,et al. Incorporation of heparin‐binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[70] P. Cuevas,et al. Basic fibroblast growth factor (FGF) promotes cartilage repair in vivo. , 1988, Biochemical and biophysical research communications.
[71] Joungho Han,et al. Synergistic Effect of Keratinocyte Transplantation and Epidermal Growth Factor Delivery on Epidermal Regeneration , 2005, Cell transplantation.
[72] F. Lin,et al. Rapid Prototyping Three-Dimensional Cell/Gelatin/Fibrinogen Constructs for Medical Regeneration: , 2007 .
[73] A. Sahni,et al. Binding of Basic Fibroblast Growth Factor to Fibrinogen and Fibrin* , 1998, The Journal of Biological Chemistry.
[74] David J Mooney,et al. Comparison of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in SCID mice. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[75] T. Segura,et al. Hyaluronic acid and fibrin hydrogels with concentrated DNA/PEI polyplexes for local gene delivery. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[76] R. Bucala,et al. Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[77] Jan P Stegemann,et al. Phase-separated chitosan–fibrin microbeads for cell delivery , 2011, Journal of microencapsulation.
[78] J. Isner,et al. Accelerated restitution of endothelial integrity and endothelium-dependent function after phVEGF165 gene transfer. , 1996, Circulation.
[79] J. Levin,et al. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits , 1999, Nature Medicine.
[80] L. Currie,et al. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: a review. , 2001, Plastic and reconstructive surgery.
[81] J. Vacanti,et al. Experimental Use of Fibrin Glue to Induce Site-Directed Osteogenesis from Cultured Periosteal Cells , 2000, Plastic and reconstructive surgery.
[82] P. Kavehpour,et al. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. , 2010, Biomaterials.
[83] Byung-Soo Kim,et al. Controlled release of nerve growth factor from fibrin gel. , 2007, Journal of biomedical materials research. Part A.
[84] Lissy K Krishnan,et al. Development of a fibrin composite-coated poly(epsilon-caprolactone) scaffold for potential vascular tissue engineering applications. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[85] S. Sakiyama-Elbert,et al. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[86] Guangzhi Wang,et al. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix. , 2008, Medical hypotheses.
[87] J. Massagué,et al. Human platelet-derived transforming growth factor-beta stimulates parameters of bone growth in fetal rat calvariae. , 1986, Endocrinology.
[88] Ulrich Kneser,et al. Fibrin Gel-Immobilized VEGF and bFGF Efficiently Stimulate Angiogenesis in the AV Loop Model , 2007, Molecular medicine.
[89] M. Garry,et al. Functional Regeneration of Chronically Injured Sensory Afferents into Adult Spinal Cord after Neurotrophin Gene Therapy , 2001, The Journal of Neuroscience.
[90] G. De Cicco,et al. Human fibrinogen/thrombin-coated collagen patch to control intraoperative severe pulmonary hemorrhage and air leakage after correction of a ruptured thoracic aortic aneurysm. , 2011, The Annals of thoracic surgery.
[91] Sang-Hyug Park,et al. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. , 2005, Artificial organs.
[92] S Tamai,et al. Arthroscopic meniscal repair using fibrin glue. Part I: Experimental study. , 1997, Arthroscopy : the journal of arthroscopic & related surgery : official publication of the Arthroscopy Association of North America and the International Arthroscopy Association.
[93] S. Waldman,et al. Genipin Cross-Linked Fibrin Hydrogels for in vitro Human Articular Cartilage Tissue-Engineered Regeneration , 2009, Cells Tissues Organs.
[94] Dong-Woo Cho,et al. Surface modification with fibrin/hyaluronic acid hydrogel on solid-free form-based scaffolds followed by BMP-2 loading to enhance bone regeneration. , 2011, Bone.
[95] A. Condurache,et al. VEGF(165) and bFGF protein-based therapy in a slow release system to improve angiogenesis in a bioartificial dermal substitute in vitro and in vivo. , 2007, Langenbeck's archives of surgery (Print).
[96] Randall J Lee,et al. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. , 2004, Tissue engineering.
[97] David G Simpson,et al. Electrospun fibrinogen: feasibility as a tissue engineering scaffold in a rat cell culture model. , 2007, Journal of biomedical materials research. Part A.
[98] Frank Baaijens,et al. A knitted, fibrin-covered polycaprolactone scaffold for tissue engineering of the aortic valve. , 2006, Tissue engineering.
[99] D. Clemmons,et al. Ligand occupancy of the alpha-V-beta3 integrin is necessary for smooth muscle cells to migrate in response to insulin-like growth factor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[100] Ge Zhang,et al. Matrices and scaffolds for drug delivery in vascular tissue engineering. , 2007, Advanced drug delivery reviews.
[101] H. Yanaga,et al. Fibrin stimulates the proliferation of human keratinocytes through the autocrine mechanism of transforming growth factor-alpha and epidermal growth factor receptor. , 2005, The Tohoku journal of experimental medicine.
[102] Buddy D Ratner,et al. Microporous nanofibrous fibrin-based scaffolds for bone tissue engineering. , 2008, Biomaterials.
[103] C. Doillon,et al. Heparin-fibroblast growth factor-fibrin complex: in vitro and in vivo applications to collagen-based materials. , 1994, Biomaterials.
[104] H. Paik,et al. Fabricating Fibrinogen Microfibers with Aligned Nanostructure, as Biodegradable Threads for Tissue Engineering , 2012 .
[105] K. Chennazhi,et al. Development of novel fibrinogen nanoparticles by two-step co-acervation method. , 2010, International journal of biological macromolecules.
[106] C. Lewis,et al. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro , 2004, Angiogenesis.
[107] M. Kurosaka,et al. Meniscal repair using fibrin sealant and endothelial cell growth factor , 1992, The American journal of sports medicine.
[108] Soon Hee Kim,et al. Fibrin and poly(lactic-co-glycolic acid) hybrid scaffold promotes early chondrogenesis of articular chondrocytes: an in vitro study , 2008, Journal of orthopaedic surgery and research.
[109] K. Fujikawa,et al. Alpha(1)-proteinase inhibitor, alpha(1)-antichymotrypsin, or alpha(2)-macroglobulin is required for vascular smooth muscle cell spreading in three-dimensional fibrin gel. , 2000, The Journal of biological chemistry.
[110] Byung-Soo Kim,et al. Delivery of basic fibroblast growth factor using heparin-conjugated fibrin for therapeutic angiogenesis. , 2010, Tissue engineering. Part A.
[111] T. V. van Gulik,et al. Evolution of fibrinogen-coated collagen patch for use as a topical hemostatic agent. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[112] K. Ishikawa,et al. Basic Fibroblast Growth Factor Increases Regional Myocardial Blood Flow and Salvages Myocardium in the Infarct Border Zone in a Rabbit Model of Acute Myocardial Infarction , 1999, Angiology.
[113] T. Sastry,et al. An in vivo study of hydrogels based on physiologically clotted fibrin-gelatin composites as wound-dressing materials. , 2004, Journal of biomedical materials research. Part B, Applied biomaterials.
[114] R. Reis,et al. Drug delivery therapies I General trends and its importance on bone tissue engineering applications , 2002 .
[115] A. Tessler,et al. Neurotrophic agents in fibrin glue mediate adult dorsal root regeneration into spinal cord. , 1999, Neurosurgery.
[116] E. Bröcker,et al. Transplantation of Autologous Keratinocyte Suspension in Fibrin Matrix to Chronic Venous Leg Ulcers: Improved Long‐Term Healing after Removal of the Fibrin Carrier , 2008, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].
[117] T. Albrektsson,et al. Fibrin adhesive system (FAS) influence on bone healing rate: a microradiographical evaluation using the bone growth chamber. , 1982, Acta orthopaedica Scandinavica.
[118] G. Bowlin,et al. Electrospun Fibrinogen-Polydioxanone Composite Matrix: Potential for in Situ Urologic Tissue Engineering , 2008 .
[119] S Jockenhoevel,et al. Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering. , 2000, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[120] A. Wittkampf. Fibrin glue as cement for HA-granules. , 1989, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[121] Y. Morimoto,et al. Fibrinogen microspheres as novel drug delivery systems for antitumor drugs. , 1986, Chemical & pharmaceutical bulletin.
[122] Frank P T Baaijens,et al. Fibrin as a cell carrier in cardiovascular tissue engineering applications. , 2005, Biomaterials.
[123] Yu-lin Yang,et al. Bone Morphogenetic Protein Gene Therapy Using a Fibrin Scaffold for a Rabbit Spinal-Fusion Experiment , 2006, Neurosurgery.
[124] Won Ho Park,et al. Fabrication and characterization of 3-dimensional PLGA nanofiber/microfiber composite scaffolds , 2010 .
[125] K. Na,et al. Bone morphogenic protein-2 (BMP-2) loaded nanoparticles mixed with human mesenchymal stem cell in fibrin hydrogel for bone tissue engineering. , 2009, Journal of bioscience and bioengineering.
[126] D. Maguire,et al. A novel in vitro assay for human angiogenesis. , 1996, Laboratory investigation; a journal of technical methods and pathology.
[127] Glenn D Prestwich,et al. Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.
[128] T. Sokoloski,et al. Fibrin-Based Drug Delivery Systems. II. The Preparation and Characterization of Microbeads , 1994 .
[129] A Liljeborg,et al. Native fibrin gel networks observed by 3D microscopy, permeation and turbidity. , 1989, Biochimica et biophysica acta.
[130] Thanavel Rajangam,et al. Improved fibronectin-immobilized fibrinogen microthreads for the attachment and proliferation of fibroblasts , 2013, International journal of nanomedicine.
[131] R. Coleman,et al. Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. , 2004, The Annals of thoracic surgery.
[132] D. Heimbach,et al. Basic fibroblast growth factor in the early human burn wound. , 1994, The Journal of surgical research.
[133] S. Werner,et al. Keratinocyte growth factor: a unique player in epithelial repair processes. , 1998, Cytokine & growth factor reviews.
[134] J. Isner,et al. Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. , 1995, Circulation.
[135] K. Siebenlist,et al. The Structure and Biological Features of Fibrinogen and Fibrin , 2001, Annals of the New York Academy of Sciences.
[136] S. Andreadis,et al. Biomimetic delivery of keratinocyte growth factor upon cellular demand for accelerated wound healing in vitro and in vivo. , 2005, The American journal of pathology.
[137] A. Pandit,et al. The use of therapeutic gene eNOS delivered via a fibrin scaffold enhances wound healing in a compromised wound model. , 2008, Biomaterials.
[138] D. Seliktar,et al. Polymer-conjugated albumin and fibrinogen composite hydrogels as cell scaffolds designed for affinity-based drug delivery. , 2011, Acta biomaterialia.
[139] Debby Gawlitta,et al. Properties of engineered vascular constructs made from collagen, fibrin, and collagen-fibrin mixtures. , 2004, Biomaterials.
[140] J. Koebke,et al. Meniscal healing: A histological study in rabbits , 2005, Knee Surgery, Sports Traumatology, Arthroscopy.
[141] V. Marder. Identification and purification of fibrinogen degradation products produced by plasmin: considerations on the structure of fibrinogen. , 2009, Scandinavian journal of haematology. Supplementum.
[142] K. Kubota,et al. Gelation dynamics and gel structure of fibrinogen. , 2004, Colloids and surfaces. B, Biointerfaces.
[143] J. Isner,et al. Stent endothelialization. Time course, impact of local catheter delivery, feasibility of recombinant protein administration, and response to cytokine expedition. , 1997, Circulation.
[144] J. Mcdonald,et al. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[145] R. Misra,et al. Chitosan-gelatin scaffolds for tissue engineering: physico-chemical properties and biological response of buffalo embryonic stem cells and transfectant of GFP-buffalo embryonic stem cells. , 2009, Acta biomaterialia.
[146] T. Sokoloski,et al. Fibrin-based drug delivery systems III: The evaluation of the release of macromolecules from microbeads , 1995 .
[147] D. Sierra,et al. Experimental and clinical applications of fibrin glue. , 1991, Plastic and reconstructive surgery.
[148] Min-Li Zhao,et al. A fibrin gel loaded with chitosan nanoparticles for local delivery of rhEGF: preparation and in vitro release studies , 2011, Journal of materials science. Materials in medicine.
[149] M. Fussenegger,et al. Stabilized Autologous Fibrin-Chondrocyte Constructs for Cartilage Repair in Vivo , 2003, Annals of plastic surgery.
[150] A. Pandit,et al. Fibrin as a delivery system for therapeutic drugs and biomolecules. , 2009, Tissue engineering. Part B, Reviews.
[151] R. Seitelberger,et al. Experimental use of a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. , 1994, The Journal of thoracic and cardiovascular surgery.
[152] S. Thorpe,et al. The application of plastic compression to modulate fibrin hydrogel mechanical properties. , 2012, Journal of the mechanical behavior of biomedical materials.
[153] Jan P Stegemann,et al. Review: advances in vascular tissue engineering using protein-based biomaterials. , 2007, Tissue engineering.
[154] Masaru Tanaka,et al. Control of neural stem cell differentiation on honeycomb films , 2008 .
[155] D. Cosgrove,et al. Randomized clinical trial of fibrin sealant in patients undergoing resternotomy or reoperation after cardiac operations. A multicenter study. , 1989, The Journal of thoracic and cardiovascular surgery.
[156] J. Feijen,et al. Release of model proteins and basic fibroblast growth factor from in situ forming degradable dextran hydrogels. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[157] A. Sahni,et al. Vascular endothelial growth factor binds to fibrinogen and fibrin and stimulates endothelial cell proliferation. , 2000, Blood.
[158] F. Gage,et al. Cellular Delivery of Neurotrophin-3 Promotes Corticospinal Axonal Growth and Partial Functional Recovery after Spinal Cord Injury , 1997, The Journal of Neuroscience.
[159] K. Chennazhi,et al. 5-fluorouracil loaded fibrinogen nanoparticles for cancer drug delivery applications. , 2011, International journal of biological macromolecules.
[160] Jie Zhou,et al. Application of collagen-chitosan/fibrin glue asymmetric scaffolds in skin tissue engineering , 2010, Journal of Zhejiang University SCIENCE B.
[161] Thomas A. Mustoe, MD, FACS,et al. Fibrin sealant combined with fibroblasts and platelet‐derived growth factor enhance wound healing in excisional wounds , 2009, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[162] R. Clark,et al. Fibronectin and fibrin provide a provisional matrix for epidermal cell migration during wound reepithelialization. , 1982, The Journal of investigative dermatology.
[163] Sang-Hyug Park,et al. Chondrogenesis of rabbit mesenchymal stem cells in fibrin/hyaluronan composite scaffold in vitro. , 2011, Tissue engineering. Part A.
[164] Shangtian Yang,et al. Three-dimensional fibrous scaffolds with microstructures and nanotextures for tissue engineering , 2012 .
[165] M. Takada,et al. Preparation and evaluation in vitro and in vivo of fibrinogen microspheres containing adriamycin. , 1986, Chemical & pharmaceutical bulletin.
[166] A. Mikos,et al. Gene delivery strategies for cartilage tissue engineering. , 2006, Advanced drug delivery reviews.
[167] R. Hendel,et al. Phase 1/2 Placebo-Controlled, Double-Blind, Dose-Escalating Trial of Myocardial Vascular Endothelial Growth Factor 2 Gene Transfer by Catheter Delivery in Patients With Chronic Myocardial Ischemia , 2002, Circulation.
[168] E. Mihályi,et al. Cross-Linking of Bovine Fibrinogen with Formaldehyde. , 1963 .
[169] J. Hubbell,et al. Development of growth factor fusion proteins for cell‐triggered drug delivery , 2001, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[170] M. Noda,et al. In vivo stimulation of bone formation by transforming growth factor-beta. , 1989, Endocrinology.
[171] H J Mankin,et al. Articular cartilage: tissue design and chondrocyte-matrix interactions. , 1998, Instructional course lectures.
[172] D. Seliktar,et al. Biosynthetic hydrogel scaffolds made from fibrinogen and polyethylene glycol for 3D cell cultures. , 2005, Biomaterials.
[173] R. Clark,et al. Human fibroblasts bind directly to fibrinogen at RGD sites through integrin alpha(v)beta3. , 1997, Experimental cell research.
[174] Mohana Marimuthu and Sanghyo Kim. Survey of the State of the Art in Biomaterials, Cells, Genes and Proteins Integrated into Micro- and Nanoscaffolds for Tissue Regeneration , 2009 .
[175] Göran Lundborg,et al. Spatial‐Temporal progress of peripheral nerve regeneration within a silicone chamber: Parameters for a bioassay , 1983, The Journal of comparative neurology.
[176] Franz E Weber,et al. Bone repair with a form of BMP-2 engineered for incorporation into fibrin cell ingrowth matrices. , 2005, Biotechnology and bioengineering.
[177] H. Varma,et al. Fibrin glue as an osteoinductive protein in a mouse model. , 2002, Biomaterials.
[178] G. Balian,et al. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin-binding fragment , 1981, The Journal of experimental medicine.
[179] H. Greisler,et al. Enhanced endothelialization of expanded polytetrafluoroethylene grafts by fibroblast growth factor type 1 pretreatment. , 1992, Surgery.
[180] E. Rosenzweig,et al. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. , 2006, Journal of controlled release : official journal of the Controlled Release Society.
[181] W. Chen,et al. Characterization of biologic properties of wound fluid collected during early stages of wound healing. , 1992, The Journal of investigative dermatology.
[182] H. Matras. Fibrin seal: the state of the art. , 1985, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[183] K. Sueishi,et al. Effects of fibrin on the angiogenesis in vitro of bovine endothelial cells in collagen gel , 1995, In Vitro Cellular & Developmental Biology - Animal.
[184] R. Albin. Regeneration , 1993, Neurology.
[185] J. Feijen,et al. Cross-linking of dermal sheep collagen using a water-soluble carbodiimide. , 1996, Biomaterials.
[186] M. Pittenger,et al. Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.
[187] Giorgio Terenghi,et al. Stem‐cell plasticity and therapy for injuries of the peripheral nervous system , 2004, Biotechnology and applied biochemistry.
[188] A. Vexler,et al. Fibrin microbeads for isolating and growing bone marrow-derived progenitor cells capable of forming bone tissue. , 2002, Tissue engineering.
[189] S. Willerth,et al. Approaches to neural tissue engineering using scaffolds for drug delivery. , 2007, Advanced drug delivery reviews.
[190] J. Han,et al. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors. , 2006, Microvascular research.
[191] G. Bowlin,et al. Cross-linking methods of electrospun fibrinogen scaffolds for tissue engineering applications , 2008, Biomedical materials.
[192] Gary L. Bowlin,et al. The Use of Natural Polymers in Tissue Engineering: A Focus on Electrospun Extracellular Matrix Analogues , 2010 .
[193] D. Mooney,et al. Growth factor delivery-based tissue engineering: general approaches and a review of recent developments , 2011, Journal of The Royal Society Interface.
[194] R E Horch,et al. Transplantation of cultured autologous keratinocytes in fibrin sealant biomatrix to resurface chronic wounds. , 2001, Transplantation proceedings.
[195] J. Bowersox,et al. Chemotaxis of aortic endothelial cells in response to fibronectin. , 1982, Cancer research.
[196] F. Boschetti,et al. Healing of meniscal tissue by cellular fibrin glue: an in vivo study , 2009, Knee Surgery, Sports Traumatology, Arthroscopy.
[197] P. Desai,et al. Fibrinogen-Coated Droplets of Olive Oil for Delivery of Docetaxel to a Fibrin(ogen)-Rich Ascites Form of a Murine Mammary Tumor , 2004, Clinical Cancer Research.
[198] J. Hubbell,et al. Covalently conjugated VEGF--fibrin matrices for endothelialization. , 2001, Journal of controlled release : official journal of the Controlled Release Society.
[199] T. Sastry,et al. Fibrin–Chitosan–Gelatin Composite Film: Preparation and Characterization , 2005 .
[200] Abhay Pandit,et al. A temporal gene delivery system based on fibrin microspheres. , 2011, Molecular pharmaceutics.
[201] L. Broemeling,et al. The Safety and Effect of Topically Applied Recombinant Basic Fibroblast Growth Factor on the Healing of Chronic Pressure Sores , 1992, Annals of surgery.
[202] Sanghyo Kim,et al. Implantable microdevice for peripheral nerve regeneration: materials and fabrications , 2011 .